glp 1 community GLP-1 medications are transforming how we approach weight loss. This session examines potential side effects, emerging questions about long-term use, and how these drugs affect the body during and after treatment. The Thinking about GLP 1s but

High-protein, moderate-fiber meals tend to be tolerated best

Schedule regular check-ins with your healthcare provider to stay accountable

Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease

A nanocarrier approach for oral peptide delivery: evaluation of cell-penetrating-peptide-modified liposomal formulations in dogs

High blood pressure, high cholesterol, heart disease, and sleep apnea can all compromise blood flow to your optic nerve and retina

To summarize the open-label extension of VESPER-1, berobenatide 2.4 mg weekly demonstrated 16% weight loss at 32 weeks, a favorable benefit-risk profile for monthly dosing, and safety and tolerability consistent with the class with no discontinuations related to gastrointestinal adverse events, and the gastrointestinal tolerability was excellent, said John B